ArticleClinical ophthalmology (Auckland, N.Z.)2023

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence.

Debdulal Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.